SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending amid government shutdown vote anticipation and the potential release of Epstein files, leading to market uncertainty. The community is discussing potential outcomes, including a 'sell the news' event if the government reopens, and the impact of missing economic data. Sector rotation out of tech and precious metals potentially signaling economic concerns are also being debated.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid renewed discussions around Jeffrey Epstein, with community members sharing news articles and email excerpts referencing Trump. Some users express concern and call for the release of related files, while others dismiss the information as politically motivated. The stock's performance and association with Trump's political brand continue to fuel debate.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending due to Shah Capital's renewed push for a company sale, citing frustration with underperformance and unmet potential, sparking community debate about management's competence and potential proxy fights. Shareholders are actively discussing the possibility of a buyout and expressing dissatisfaction with the current leadership, particularly regarding partnership progress and market share. The community's sentiment is further fueled by concerns over dilution and the lack of communication from Novavax regarding Shah Capital's concerns.

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Formela, Joshua Rosenthal, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.

Korro Bio Inc.

Korro Bio ($KRRO) is trending due to mixed reactions to recent news, including restructuring charges and a paused research program alongside the announcement of a $70M private placement. While some investors are wary of these developments, others see the dip as a buying opportunity, citing the company's substantial cash reserves and RNA editing technology. Community discussions revolve around potential for a bounce and comparisons to other companies in the RNA editing space.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending due to a mix of factors, including upcoming earnings and speculation around the IPO lock-up period, which could lead to increased selling pressure; community debates are swirling around its long-term value and potential for a bounce. Despite strong growth in USDC circulation, some express concern about increasing competition and broader market conditions impacting crypto-related stocks.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is seeing active discussion around AI valuations and the potential for a tech sector rotation. Community members are debating whether the government shutdown ending will be a "sell the news" event, while also eyeing key technical levels and reacting to intraday price swings. Some traders are closely monitoring potential implications from delayed economic data releases and the unfolding Epstein files.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco's earnings beat and raised guidance are driving community discussion, with some seeing it as a pure technical breakout while others question if the numbers warrant the move. Investors are debating the company's AI prospects and its potential to capitalize on the AI datacenter buildout, with some drawing parallels to the dot-com era boom and bust.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp is trending as investors digest recent earnings and future revenue guidance, with debates focused on the impact of non-cash expenses and new industrial contracts. Bullish sentiment centers on the company's potential growth in 2026 and discussions around government support for domestic antimony production. Community members are actively discussing revenue projections and speculating on future contracts related to tungsten and cobalt.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly (DPRO) is trending amid discussions about a new partnership and its participation in the AUSA Annual Meeting & Exposition. The community is actively discussing the company's potential in the defense sector, especially regarding drone technology for the U.S. Army, as well as speculation about the impact of new contracts on revenue growth and profitability.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

ORCL is trending due to concerns about its debt and spending related to AI infrastructure, leading to a significant pullback from recent highs. Community members are expressing frustration with the stock's persistent decline and lack of management communication, while some speculate about potential accounting issues and the overall sustainability of the AI hype. The stock's performance is being closely watched in the context of broader market trends and the AI sector's future.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Price Up 8.4% - Here's Why

MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Up 8.4% - Time to Buy...

CLASS ACTION REMINDER: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Lawsuit by December 15, 2025

CLASS ACTION REMINDER: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Inquire About a Securities Fraud Lawsuit by December 15, 2025 CLASS ACTION REMINDER: Berger...

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

MLTX SHAREHOLDER NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman MLTX...

MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX

MoonLake Immunotherapeutics Class Action: The Gross Law Firm Reminds MoonLake Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 15, 2025 - MLTX MoonLake...

FY2025 EPS Estimates for MLTX Decreased by Leerink Partnrs

MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Equities researchers at Leerink Partnrs cut their FY2025 earnings per share estimates for shares of MoonLake Immunotherapeutics in a research...

Equities Analysts Offer Predictions for MLTX FY2025 Earnings

MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Stock analysts at Wedbush decreased their FY2025 EPS estimates for MoonLake Immunotherapeutics in a research report issued to clients and...

FY2029 Earnings Forecast for MLTX Issued By Wedbush

MoonLake Immunotherapeutics (NASDAQ:MLTX - Free Report) - Analysts at Wedbush decreased their FY2029 EPS estimates for MoonLake Immunotherapeutics in a research note issued to investors on Wednesday...

MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Average Recommendation of "Hold" from Analysts

MoonLake Immunotherapeutics (NASDAQ:MLTX - Get Free Report) has been given an average recommendation of "Hold" by the fifteen ratings firms that are currently covering the stock, Marketbeat Ratings...

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...

MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit MLTX INVESTOR DEADLINE: MoonLake Immunotherapeutics...

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

MLTX
MoonLake Immunotherapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest MLTX News

MLTXMoonLake Immunotherapeutics